![](/img/cover-not-exists.png)
PDB62 COST-UTILITY ANALYSIS OF SAXAGLIPTIN AS AN ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES PATIENTS FROM THE BRAZILIAN PRIVATE HEALTH SYSTEM
FG Eliaschewitz, E Asano, ME Nita, R Rached, BM DonatoVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)72120-9
File:
PDF, 79 KB
english, 2010